Literature DB >> 1705993

Equine infectious anemia virus and human immunodeficiency virus DNA synthesis in vitro: characterization of the endogenous reverse transcriptase reaction.

K Borroto-Esoda1, L R Boone.   

Abstract

The endogenous reverse transcriptase reaction of equine infectious anemia virus (EIAV) has been studied, and conditions allowing synthesis of full-length minus-strand DNA have been determined. In contrast to results reported for other retroviruses, synthesis of EIAV full-length minus-strand DNA was not impaired by high concentrations of Nonidet P-40, a nonionic detergent used to make the virion envelope permeable. All components of the reaction were titrated for maximum synthesis of complete minus strands, and a time course under the standardized conditions was determined. Minor subgenomic bands were observed in some cases, and both the size and proportion varied with reaction conditions. Conditions established for full-length EIAV DNA synthesis also allowed full-genome-length human immunodeficiency virus type 1 DNA synthesis. The human immunodeficiency virus type 1 DNA product contained a greater proportion of reverse transcripts that were shorter than the complete virus genome. Also in contrast to EIAV, the endogenous synthesis of high-molecular-weight human immunodeficiency virus type 1 DNA was drastically reduced at Nonidet P-40 concentrations above 0.02%. These results indicated that a detergent-stable core is not a property shared by all lentiviruses. The EIAV virion synthetic machinery is unusually stable and provides a convenient system for further in vitro study of reverse transcription.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1705993      PMCID: PMC240025     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  The preparation and biochemical characterization of intact capsids of equine infectious anemia virus.

Authors:  M M Roberts; S Oroszlan
Journal:  Biochem Biophys Res Commun       Date:  1989-04-28       Impact factor: 3.575

2.  A retroviral RNA secondary structure required for efficient initiation of reverse transcription.

Authors:  D Cobrinik; L Soskey; J Leis
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

3.  Azidothymidine triphosphate is an inhibitor of both human immunodeficiency virus type 1 reverse transcriptase and DNA polymerase gamma.

Authors:  H König; E Behr; J Löwer; R Kurth
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

4.  HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy.

Authors:  B A Larder; G Darby; D D Richman
Journal:  Science       Date:  1989-03-31       Impact factor: 47.728

5.  RNA-dependent DNA polymerase activity in five RNA viruses: divalent cation requirements.

Authors:  E Scolnick; E Rands; S A Aaronson; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1970-12       Impact factor: 11.205

6.  Nucleotide sequence analysis of equine infectious anemia virus proviral DNA.

Authors:  T Kawakami; L Sherman; J Dahlberg; A Gazit; A Yaniv; S R Tronick; S A Aaronson
Journal:  Virology       Date:  1987-06       Impact factor: 3.616

7.  Molecular cloning and polymorphism of the human immune deficiency virus type 2.

Authors:  F Clavel; M Guyader; D Guétard; M Sallé; L Montagnier; M Alizon
Journal:  Nature       Date:  1986 Dec 18-31       Impact factor: 49.962

8.  Infectious potential of human immunodeficiency virus type 1 reverse transcriptase mutants with altered inhibitor sensitivity.

Authors:  B A Larder; S D Kemp; D J Purifoy
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

9.  Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT).

Authors:  B A Larder; S D Kemp
Journal:  Science       Date:  1989-12-01       Impact factor: 47.728

10.  Equine infectious anemia virus derived from a molecular clone persistently infects horses.

Authors:  L Whetter; D Archambault; S Perry; A Gazit; L Coggins; A Yaniv; D Clabough; J Dahlberg; F Fuller; S Tronick
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

View more
  24 in total

1.  HIV-1 DNA Flap formation promotes uncoating of the pre-integration complex at the nuclear pore.

Authors:  Nathalie J Arhel; Sylvie Souquere-Besse; Sandie Munier; Philippe Souque; Stéphanie Guadagnini; Sandra Rutherford; Marie-Christine Prévost; Terry D Allen; Pierre Charneau
Journal:  EMBO J       Date:  2007-06-07       Impact factor: 11.598

2.  Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell.

Authors:  O Schwartz; V Maréchal; O Danos; J M Heard
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

3.  Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors.

Authors:  W A O'Brien; A Namazi; H Kalhor; S H Mao; J A Zack; I S Chen
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

4.  Amphipathic domains in the C terminus of the transmembrane protein (gp41) permeabilize HIV-1 virions: a molecular mechanism underlying natural endogenous reverse transcription.

Authors:  H Zhang; G Dornadula; P Alur; M A Laughlin; R J Pomerantz
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

5.  Localized sequence heterogeneity in the long terminal repeats of in vivo isolates of equine infectious anemia virus.

Authors:  W Maury; S Perryman; J L Oaks; B K Seid; T Crawford; T McGuire; S Carpenter
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

6.  Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain.

Authors:  T Masuda; V Planelles; P Krogstad; I S Chen
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  Mechanism of resistance of human immunodeficiency virus type 1 to 2',3'-dideoxyinosine.

Authors:  J L Martin; J E Wilson; R L Haynes; P A Furman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

8.  Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection.

Authors:  M I Bukrinsky; N Sharova; T L McDonald; T Pushkarskaya; W G Tarpley; M Stevenson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

9.  Strand transfer and elongation of HIV-1 reverse transcription is facilitated by cell factors in vitro.

Authors:  David Warrilow; Kylie Warren; David Harrich
Journal:  PLoS One       Date:  2010-10-06       Impact factor: 3.240

Review 10.  When is it time for reverse transcription to start and go?

Authors:  Marylène Mougel; Laurent Houzet; Jean-Luc Darlix
Journal:  Retrovirology       Date:  2009-03-04       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.